Multicenter phase II feasibility trial of high-dose tamoxifen in patients with refractory or relapsed multiple myeloma.

Decaudin, Didier; Etienne, Marie-Christine; De Cremoux, Patricia; Maciorowski, Zofia; Vantelon, Jean-Marie; Voog, Eric; Urien, SaIk; Tran-Perennou, Carine; Renée, Nicole; Vielh, Philippe; Némati, Fariba; Pouillart, Pierre

Decaudin, Didier; Etienne, Marie-Christine; De Cremoux, Patricia; Maciorowski, Zofia; Vantelon, Jean-Marie; Voog, Eric; Urien, SaIk; Tran-Perennou, Carine; Renée, Nicole; Vielh, Philippe; Némati, Fariba; Pouillart, Pierre.

J Natl Cancer Inst ; 96(8): 636-7, 2004 Apr 21.

Article in En | MEDLINE | ID: mdl-15100346

Subject(s)

Antineoplastic Agents, Hormonal/administration & dosage; Antineoplastic Agents, Hormonal/pharmacokinetics; Estrogen Receptor Modulators/administration & dosage; Estrogen Receptor Modulators/pharmacokinetics; Multiple Myeloma/drug therapy; Tamoxifen/administration & dosage; Tamoxifen/pharmacokinetics; Antineoplastic Agents, Hormonal/adverse effects; Antineoplastic Agents, Hormonal/blood; Chromatography, High Pressure Liquid; Drug Administration Schedule; Estrogen Receptor Modulators/adverse effects; Estrogen Receptor Modulators/blood; Feasibility Studies; Humans; Receptors, Estrogen/metabolism; Receptors, Progesterone/metabolism; Tamoxifen/adverse effects; Tamoxifen/blood; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Tamoxifen / Antineoplastic Agents, Hormonal / Estrogen Receptor Modulators / Multiple Myeloma Type of study: Clinical_trials Limits: Humans Language: En Journal: J Natl Cancer Inst Year: 2004 Document type: Article Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links